NCT01949337
Clinical Trial Information
Trial Number: NCT01949337 (ClinicalTrials.gov)
Disease Type:
- Reproductive System Neoplasm, Male - Prostate Cancer
Trial Title:
Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
Study ID:
A031201
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01949337-D4 | This dataset contains enzalutamide-based PK data which can be input into Pumas PK software to produce final PK results. Three other datasets for PMID 36996380 contain baseline characteristics, outcome data, adverse events, and additional PK data. |
| NCT01949337-D3 | This dataset contains abiraterone based PK data that can be input into Pumas PK software to produce PK results. Three other datasets for PMID 36996380 contain baseline characteristics, outcome data, adverse events, and additional PK data. |
| NCT01949337-D2 | This dataset contains data for adverse event analyses and tables. Three other datasets for PMID 36996380 contain baseline characteristics, outcome data, and PK data. |
| NCT01949337-D1 | This dataset contains data for the baseline characteristics table, primary analysis and secondary analyses minus adverse event and PK analyses. Three other datasets for PMID 36996380 contain adverse event and PK data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®